Cyclosporine for treating rheumatoid arthritis

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 7, 1998, Pages

  Wells, George A ^a   Haguenauer, Didier ^b   Shea, Beverley ^c   Suarez Almazor, Maria E ^d   Welch, Vivian ^c   Tugwell, Peter ^e   Peterson, Joan ^f  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b Versailles Saint Quentin en Yvelines University   (France)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF OTTAWA   (Canada)

^f OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85019588677     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001083     Document Type: Article

References (15)

1. Dougados M, Awada H, Amor B. Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients. Ann Rheum Dis 1998;47:127-33.
2. Forre O and the Norvegian Arthritis Study Group. Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Arthritis Rheum 1994;37:1506-12.
3. Tugwell P, Bombardier C, Gent M, et al. Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet 1990;335:1051-5.
4. Van Rijthoven A, Dijkmans BA, Goei The H, et al. Cyclosporin treatment for rheumathoid arthritis: a placebo controlled, double-blind, multicenter study. Ann Rheum Dis 1986;45:726-31.
5. Dickersin K, Scherer R., Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309:1286-91.
6. Dougados M, Duchene l, Amor B. Bromocriptin and cyclosporine A combination therapy in rheumatoid arthritis. Arthritis Rheum 1988;31:1331-4.
7. Dougados M, Torley H. Efficacy of cyclosporin A in rheumatoid arthritis: worldwide experience. Br J Rheum 1993;32(suppl 1):57-9.
8. Gepner, Amor B, Fournier C. 1.25. hydroxy vitamin D3 potentiates the in vitro inhibitory effects of cyclosporine A on T cells from rheumatoid arthritis patients. Arthritis Rheum 1989;22:31-4.
9. Hess A, Turschka P, Pu Z, et al. Effects of cyclosporine A on human lymphocyte response in vitro. J Immunol 1982;128:360-7.
10. An International consensus report: the use of cyclosporin A in rheumatoid arthritis. Br J Rheum 1993;32(suppl 1):1-3.
11. Jadad A, Moore A, Carrol D, et al. Assessing the quality of reports of randomized trials: is blinding necessary?. Control Clin Trial 1996;17:1-12.
12. Kruger K, Schattenkirchner M. Cyclosporine versus azathioprine in the treatment of rheumatoid arthritis; results of a controlled double blind multicenter study(abstract). J Autoimmun 1992;5, xix.
13. OMERACT. Conference on Outcome Measures in Rheumatoid Arthritis Clinical Trials. J Rheumatol 1993;20:526-91.
14. Van Rijthoven AW, Dijkmans BA, Goei The HS, et al. Comparison of cyclosporine and D penicillamine for rheumatoid arthritis: a randomized double blind multicenter study. J Rheumatol 1991;18:815-20.
15. Waalen K, Forre O, Linker M, et al. Evidence of an activated T cell system with augmented turn over of interleukin 2 in rheumatoid arthritis. Scand J Immunol 1987;25:367-73.